Explore articles tagged with Virtual Manufacturing
HRV Pharma (Group) has been recognised at the ET RE-Pharma Awards 2026 for Excellence in Pharma Global Business Support, highlighting its leadership in compliant, agile, and globally integrated pharmaceutical operations.
HRV Pharma CEO Hari Kiran Chereddi shares his insights on how Union Budget 2026–27’s focus on biopharma innovation, affordable cancer care, and healthcare infrastructure will shape India’s pharmaceutical future.
Virtual pharmaceutical manufacturing models are helping solve structural drug shortages by connecting global GMP capacity, improving supply flexibility, and strengthening regulatory execution.
HRV Pharma has entered a multi‑year strategic partnership with Haleos Labs to accelerate the development and manufacture of orphan and niche APIs, strengthening global access to complex therapies for rare diseases.
HRV Pharma’s capital‑efficient virtual pharmaceutical model is helping address America’s drug shortage crisis by linking underutilized global manufacturing capacity with regulatory strength to ensure consistent API supply.
Fortune India features HRV Pharma for pioneering a capital‑efficient virtual pharma model that is transforming India’s bulk drug and API ecosystem through speed, compliance, and global regulatory execution.
India's rise in biosimilars & biologics. Full clipping + insights included.
Workplace safety in pharma can no longer be a checklist exercise. This blog shares how HRV Pharma, led by MD & CEO Hari Kiran Chereddi, is using virtual manufacturing networks, stronger EHS governance, and ESG‑aligned practices to raise safety standards across partner sites and protect people, reputation, and India’s role as the world’s pharmacy.
HRV Pharma's CEO Hari Kiran Chereddi explores how digital intelligence and AI are transforming pharmaceutical supply chains from efficiency-driven models to resilient, adaptive networks.
HRV Pharma's CEO Hari Kiran Chereddi analyzes India's pharmaceutical transformation from affordable generics manufacturer to global hub of compliance, innovation, and supply chain excellence.
HRV Pharma's CEO Hari Kiran Chereddi explores how virtual pharmaceutical manufacturing is revolutionizing global drug access by breaking traditional factory-based models and democratizing healthcare through agile, compliant supply chains.
HRV Pharma is redefining pharmaceutical manufacturing through distributed orchestration, compliance-driven models, and technology-first strategies to build resilient, globally connected supply chains for the future.
Our CEO Hari Kiran Chereddi shares insights in Citeline Medtech Insight on India's role in global supply chains amidst US medical device tariffs.
HRV pharma's Hari Kiran Chereddi discusses AI, digital twins, and sustainable molecule design transforming Indian pharmaceutical manufacturing.
In a significant milestone for India-Argentina healthcare cooperation, HRV Pharma has successfully delivered the first consignment of USFDA-qualified Metformin to Mendoza province, achieving estimated savings of 45-50% for patients.
HRV Pharma has announced its strategic interest in expanding operations into Sri Lanka, positioning the island nation as a key growth market in the company's South Asian expansion strategy.
HRV’s CEO discusses virtual pharma models and navigating complex global markets in a CPhI Milan interview, emphasizing innovation and regulatory mastery.
HRV Pharma has been honored with two prestigious leadership awards, recognizing the company as a leading pharmaceutical enterprise in both India and the Middle East markets